Rambeck et al., 1987 - Google Patents
A vitamin D3 steroid hormone in the calcinogenic grass Trisetum flavescensRambeck et al., 1987
View PDF- Document ID
- 2016940519685635622
- Author
- Rambeck W
- Weiser H
- Zucker H
- Publication year
- Publication venue
- Zeitschrift für Naturforschung C
External Links
Snippet
The grass Trisetum flavescens (golden oat grass, Goldhafer) causes soft tissue calcification in cattle and in sheep. The calcinogenic principle of the plant is the active vitamin D steroid hormone 1, 25-Dihydroxyvitamin D3, the major physiological regulator of calcium …
- 241000005602 Trisetum flavescens 0 title abstract description 38
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DeLuca et al. | Biological activity 1, 25-dihydroxycholecalciferol | |
| Boyle et al. | The biological activity and metabolism of 24, 25-dihydroxyvitamin D3 | |
| Blunt et al. | Biological activity of 25-hydroxycholecalciferol, a metabolite of vitamin D3. | |
| Mello | Calcinosis—calcinogenic plants | |
| BAR et al. | The interaction between dietary calcium and gonadal hormones in their effect on plasma calcium, Bone, 25-Hydroxycholecalciferol-1-Hydroxylase, and Duodenal calcium-Binding Protein, Measured by a Radio-Immunoassay in Chicks | |
| US3565924A (en) | 25-hydroxycholfcalciferol | |
| US9446088B2 (en) | Preparation and use of a plant extract from solanum glaucophyllum with an enriched content of 1,25 dihydroxyvitamin D3 glycosides and quercetin glycosides | |
| Johnsson et al. | MC 1288‐A vitamin D analogue with immunosuppressive effects on heart and small bowel grafts | |
| Okamoto et al. | Biological activity of 24, 24-difluoro-1, 25-dihydroxyvitamin D3 | |
| Wrissenberg | Calcinogenic glycosides | |
| MORITA et al. | Vitamin D toxicosis in cats: natural outbreak and experimental study | |
| Rambeck et al. | A vitamin D3 steroid hormone in the calcinogenic grass Trisetum flavescens | |
| EP0385446B1 (en) | Osteogenesis promotion with use of vitamin D derivatives | |
| Conrad et al. | Effects of massive doses of vitamin D on physiological behavior of calcium in cattle | |
| JPS63107929A (en) | Drug containing novel vitamin d3 derivative as active ingredient | |
| Rambeck et al. | Synergistic effects of 1, 25 (OH) 2D3 and 24, 25 (OH) 2D3 on duodenal CaBP in rachitic chicks and on eggshell weight in Japanese quails | |
| Rambeck et al. | Synergistic effects of vitamin D metabolites | |
| Narbaitz et al. | Hypervitaminosis D in the chick embryo: comparative study on the activity of various vitamin D3 metabolites | |
| US4628050A (en) | Antinephritic pharmaceutical composition containing 24, 25-dihydroxycholecalciferol as an active ingredient | |
| Boris et al. | In vivo studies in chicks and rats of bone calcium mobilization by 1α, 25-dihydroxycholecalciferol (calcitriol) and its congeners | |
| Rambeck et al. | Biological activity of fluorine-substituted 1, 25-dihydroxyvitamin D3 in rats, in chicken and in Japanese quails | |
| NZ192603A (en) | 25-hydroxycholecalciferol-26,23-lactone and pharmaceteutical compositions | |
| EP4226913A1 (en) | Composition for use in supporting normal blood calcium concentrations in mammals | |
| US4093746A (en) | Method of and fodder for rearing white-meat calves for slaughter | |
| Moate et al. | Effect of 1, 25 dihydroxyvitamin D3 on the calcium and magnesium metabolism of lactating cows |